BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21383526)

  • 1. Differential gene expression profiles of POMC-related enzymes, transcription factors and receptors between non-pituitary and pituitary ACTH-secreting tumors.
    Tani Y; Sugiyama T; Izumiyama H; Yoshimoto T; Yamada S; Hirata Y
    Endocr J; 2011; 58(4):297-303. PubMed ID: 21383526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential gene expression in ACTH -secreting and non-functioning pituitary tumors.
    Tateno T; Izumiyama H; Doi M; Yoshimoto T; Shichiri M; Inoshita N; Oyama K; Yamada S; Hirata Y
    Eur J Endocrinol; 2007 Dec; 157(6):717-24. PubMed ID: 18057378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome.
    de Keyzer Y; Lenne F; Auzan C; Jégou S; René P; Vaudry H; Kuhn JM; Luton JP; Clauser E; Bertagna X
    J Clin Invest; 1996 Mar; 97(5):1311-8. PubMed ID: 8636444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of somatostatin and dopamine receptor subtype genes in adrenocorticotropin (ACTH)-secreting pituitary tumors and silent corticotroph adenomas.
    Tateno T; Kato M; Tani Y; Oyama K; Yamada S; Hirata Y
    Endocr J; 2009; 56(4):579-84. PubMed ID: 19318729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nur77 gene expression levels were involved in different ACTH-secretion autonomy between Cushing's disease and subclinical Cushing's disease.
    Tabuchi Y; Kitamura T; Fukuhara A; Mukai K; Onodera T; Miyata Y; Hamasaki T; Oshino S; Saitoh Y; Morii E; Otsuki M; Shimomura I
    Endocr J; 2016 Jun; 63(6):545-54. PubMed ID: 27025408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing's syndrome: constraints imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion.
    Tsagarakis S; Tsigos C; Vasiliou V; Tsiotra P; Kaskarelis J; Sotiropoulou C; Raptis SA; Thalassinos N
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1646-53. PubMed ID: 11932296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiles of pro-opiomelanocortin and encoded peptides, and their processing enzymes in equine pituitary pars intermedia dysfunction.
    Carmalt JL; Mortazavi S; McOnie RC; Allen AL; Unniappan S
    PLoS One; 2018; 13(1):e0190796. PubMed ID: 29309431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
    Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
    J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synthesis and release of CRF and ACTH in ectopic CRF/ACTH-producing tumors].
    Suda T
    Nihon Naibunpi Gakkai Zasshi; 1994 Jan; 70(1):17-24. PubMed ID: 7958079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
    Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
    Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours.
    de Keyzer Y; René P; Beldjord C; Lenne F; Bertagna X
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):475-82. PubMed ID: 9876345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
    Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
    Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2F1-mediated human POMC expression in ectopic Cushing's syndrome.
    Araki T; Liu NA; Tone Y; Cuevas-Ramos D; Heltsley R; Tone M; Melmed S
    Endocr Relat Cancer; 2016 Nov; 23(11):857-870. PubMed ID: 27935805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between tumoral GH-releasing peptide receptor type 1a mRNA expression and in vivo response to GH-releasing peptide-6 in ACTH-dependent Cushing's syndrome patients.
    Machado MC; Valeria de Sa S; Correa-Giannella ML; Giorgi RR; Pereira MA; Cescato VA; Giannella-Neto D; Salgado LR
    Eur J Endocrinol; 2008 May; 158(5):605-13. PubMed ID: 18426818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Processing of high-molecular-weight form adrenocorticotropin in human adrenocorticotropin-secreting tumor cell line (DMS-79) after transfection of prohormone convertase 1/3 gene.
    Tateno T; Kato M; Tani Y; Yoshimoto T; Oki Y; Hirata Y
    J Endocrinol Invest; 2010 Feb; 33(2):113-7. PubMed ID: 19786827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-translational processing of proopiomelanocortin (POMC) in mouse pituitary melanotroph tumors induced by a POMC-simian virus 40 large T antigen transgene.
    Low MJ; Liu B; Hammer GD; Rubinstein M; Allen RG
    J Biol Chem; 1993 Nov; 268(33):24967-75. PubMed ID: 8227058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion.
    de Herder WW; Krenning EP; Malchoff CD; Hofland LJ; Reubi JC; Kwekkeboom DJ; Oei HY; Pols HA; Bruining HA; Nobels FR
    Am J Med; 1994 Apr; 96(4):305-12. PubMed ID: 8166148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why don't corticotroph tumors always produce Cushing's disease?
    García-Martínez A; Cano DA; Flores-Martínez A; Gil J; Puig-Domingo M; Webb SM; Soto-Moreno A; Picó A
    Eur J Endocrinol; 2019 Sep; 181(3):351-361. PubMed ID: 31319379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proopiomelanocortin, glucocorticoid, and CRH receptor expression in human ACTH-secreting pituitary adenomas.
    Cassarino MF; Sesta A; Pagliardini L; Losa M; Lasio G; Cavagnini F; Pecori Giraldi F
    Endocrine; 2017 Mar; 55(3):853-860. PubMed ID: 27220856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectopic ACTH syndrome: discrepancy between somatostatin receptor status in vivo and ex vivo, and between immunostaining and gene transcription for POMC and CRH.
    Kristiansen MT; Rasmussen LM; Olsen N; Asa SL; Jørgensen JO
    Horm Res; 2002; 57(5-6):200-4. PubMed ID: 12053094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.